CD79A and COVID-19: We did not observe significant correlations between the NAbs and IgA or between the NAbs and the total IgG antibodies against the two SARS-CoV-2 strains in the COVID-19 patients (Fig. 7A, B, E, and F) or in the vaccinated individuals (Fig. 7I, J, M, and N).